BlackRock Institutional Trust’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

BlackRock Institutional Trust’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$6.99M	Buy	51,344 +11,706	+30%	+$2.08M	﹤0.01%	2600
2016 Q3	$7.89M	Buy	39,638 +6,538	+20%	+$1.13M	﹤0.01%	2483
2016 Q2	$4.29M	Buy	33,100 +10,852	+49%	+$1.21M	﹤0.01%	2758
2016 Q1	$2.08M	Sell	22,248 -177	-0.8%	-$19.3K	﹤0.01%	3022
2015 Q4	$4.55M	Buy	22,425 +337	+2%	+$60.3K	﹤0.01%	2780
2015 Q3	$3.21M	Buy	22,088 +8,553	+63%	+$1.57M	﹤0.01%	2917
2015 Q2	$2.88M	Buy	13,535 +3,764	+39%	+$923K	﹤0.01%	2972
2015 Q1	$2.26M	Buy	+9,771	New	+$2.36M	﹤0.01%	3062

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Institutional Trust's BLCM Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Bellicum Pharmaceuticals, Inc. (BLCM) stake by 30% in Q4 2016, buying an estimated $2.08M and bringing the position to 51,344 shares worth $6.99M. The position accounts for ﹤0.01% of the portfolio, ranked #2600.

BlackRock Institutional Trust first reported a position in BLCM in Q1 2015 and has held it in 8 quarters since. The position peaked at $7.89M in Q3 2016. 80 funds tracked by Wall St. Rank hold BLCM as of Q4 2016.

BlackRock Institutional Trust held 51,344 shares of Bellicum Pharmaceuticals, Inc. worth $6.99M as of Q4 2016.
BlackRock Institutional Trust bought 11,706 Bellicum Pharmaceuticals, Inc. shares in Q4 2016, an estimated $2.08M.
Bellicum Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2600 holding.
BlackRock Institutional Trust first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2015 and has held it in 8 quarters since.
BlackRock Institutional Trust's Bellicum Pharmaceuticals, Inc. position peaked at $7.89M in Q3 2016.
80 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.